Reuters says company has entered into exclusive talks
UPDATE // BREAKING NEWS : DSM to acquire Erber Group’s Biomin and Romer Labs
DSM is rumored to be among the final bidders to purchase Erber Group, according to a Reuters report.
One source told Reuters that the Dutch chemical company had entered into exclusive talks on the deal, which is valued at EUR1 billion (US$1.14 billion).
Getzersdorf, Austria-based Erber Group consists of animal feed additives producer Biomin, food safety diagnostic firm Romer Labs, animal health company Sanphar and biotech incubator EFB. According to its website, it is active in more than 130 countries, and has its own business units in about half of them. In 2018, its annual turnover was about EUR330 million.
DSM has not responded to a request for comment from Feed Strategy.
In December 2019, DSM announced the succession of CEO Feike Sijbesma to his managing board colleagues Geraldine Matchett and Dimitri de Vreeze as co-CEOs in February 2020. As co-CEOs, Matchett focuses on financial management and capital markets communication, capital allocation, talent and culture development, as well as digital strategy and new ways of working. de Vreeze focuses on operational delivery, customer centricity, driving growth and efficiency as well as innovation and R&D programs. Jointly, they are accountable for the performance of the company and drive the purpose-led, performance-driven strategy and merger and acquisition agenda.
In March 2018, Erber Group established a new company hub in the Kansas City area in order to bring Biomin and Romer Labs locations closer to each other and their respective customers, offering further support with an expanded team of industry experts.
